Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
SOPHiA GENETICS Announces Poster Presentations at ESMO 2024
-
Apogee Therapeutics to Participate at the Stifel 2024 Immunology and Inflammation Summit
-
Lyten’s Lithium-Sulfur Battery Technology Chosen to be Demonstrated on the International Space Station
-
Leafly Announces Partnership With the New York Cannabis Retail Association
-
CI Global Asset Management Announces September 2024 Distributions for the CI ETFs
-
BPGbio Presents Phase 2b BPM31510 Glioblastoma Trial-in-Progress Update and Pioneering Comprehensive Quinomics Assessment at the ESMO Congress 2024
-
CAFÉ DOMINO LAUNCHES IN NEW YORK
-
The Brain Aneurysm Foundation Hosts Annual Research Grant Symposium as the Organization Marks 30 Years of Advocacy, Innovation and Education to Prevent Fatal Ruptures
-
Moving iMage Technologies Awarded Project for State-of-the-Art Flix Brewhouse Cinema in Albuquerque
-
Realm.Security Emerges from Stealth, Raises $5M to Manage Explosion of Cyber Security Data
-
General Mills Announces Agreements to Sell Its North American Yogurt Business to Lactalis and Sodiaal
-
Who is Edwin Rubis? Getting to Know the Man Serving a 40 Year Sentence For Non-Violent Cannabis Charges - Beard Bros Media
-
Origin Materials Unveils CapFormer System, Completes Factory Acceptance Test of World’s First Commercial-Scale Manufacturing System for PET Caps
-
Unleashing Hope: Thrive Pet Healthcare and FidoCure Transform Canine Cancer Care
-
DNA Payments Launches Apple Pay Express Checkout for Ecommerce
-
Just Play Unveils Innovative HOLOBRITE Pixie Toy Featuring a Hologram Friend that Visits the Real World
-
Virtus Investment Partners Reports Preliminary August 31, 2024 Assets Under Management
-
F2G Announces $100 Million Financing to Advance Late-Stage Development and Commercialization of Novel Antifungal Drug Candidate Olorofim in the US
-
Laser Photonics Lands Sale With Acuren, Leader in Nondestructive Testing Services
-
ProMIS Neurosciences to Showcase PMN310’s Ability to Target Toxic Oligomers and Distinguish from Other Amyloid-Beta Oligomers in Preclinical Studies at the 4th International Conference on Cognitive
-
The World's First Museum Of Candy is Opening Soon In Dubai
-
Coeur Announces Achievement of Key Milestones at Expanded Rochester Mine
-
Cronus Chemicals Receives EPA Construction and Air Permit, Paving the way for its Ammonia Production Plant in the US Corn Belt
-
Yodeck Expands Global Partner Program to Generate New Service Offerings and Revenue Opportunities for Yodeck Partners
-
Aduro Clean Technologies Reports 2024 Financial Results and Provides End of Year Update
-
Oruka Therapeutics Announces Accelerated Clinical Timelines and Upcoming Presentation at EADV Supporting ORKA-001’s Profile as a Potentially Best-in-Class Half-Life Extended Antibody Targeting IL-23
-
Breckenridge Brewery Unveils Oktoberfest Brew and Hosts 28th Annual Oktoberfest Festival: A Weekend of Live Music, Traditional German Cuisine, and Tasty Brews in Breckenridge, Colorado
-
GURU Organic Energy Announces Third Quarter 2024 Financial Results
-
Factory Acceptance Test of Second-Generation Electrolyzer Completed
-
The Lovesac Company Reports Second Quarter Fiscal 2025 Financial Results
-
Green Thumb Industries Refinances its Senior Debt Via Syndicated Credit Facility
-
Moment Factory Speeds Up Its Global Expansion With An Ambitious Growth Plan
-
Equity of Opportunity at Fortune’s Best Workplaces Fuels Business Success
-
ProMIS Neurosciences to Showcase PMN310’s Ability to Target Toxic Oligomers and Distinguish from Other Amyloid-Beta Oligomers in Preclinical Studies at the 4th International Conference on Cognitive
-
OTC Markets Group Announces Official Launch of OTC Overnight, Expanding Global Market Access
-
Climb Channel Solutions Announces Keyfactor as New North American Channel Partner
-
Gauzy Ltd. Announces Purchases of Gauzy Shares by CEO, Other Senior Executives and Key Long-Term Investor
-
Genespire appoints Karen Aiach-Pignet as Chief Executive Officer
-
Bristol Myers Squibb to Report Results for Third Quarter 2024 on October 31, 2024
-
Harvey Homan to Highlight MetasTx’s Game-Changing Approach to Cancer Treatment at PA Life Science Futures
-
Aclarion Provides Corporate Update on Nociscan AI Technology Milestones
-
Auddia Inc. to Participate in the 2024 Gaming, Media & Entertainment Virtual Conference, Presented by Maxim Group LLC
-
Aclarion Provides Corporate Update on Nociscan AI Technology Milestones
-
Auddia Inc. to Participate in the 2024 Gaming, Media & Entertainment Virtual Conference, Presented by Maxim Group LLC
-
YieldMax™ Launches Option Income Strategy ETF on Super Micro Computer (SMCI)
-
Ryder Earns Quest for Quality Awards from Logistics Management
-
Dollar General Announces Partnership with World Central Kitchen in Wake of Hurricane Francine
-
AECOM declares quarterly dividend
-
Pattern Energy Appoints Matthew Rhodes as Chief Financial Officer
-
Fulcrum Therapeutics Announces Topline Results from Phase 3 REACH Clinical Trial of Losmapimod in Facioscapulohumeral Muscular Dystrophy (FSHD)
